Content
All Posts > Content under Pharma/Biotech
Nabriva Therapeutics Announces $20 Million Registered Direct Offering
Article By:
NASDAQ GlobeNewswire
Read
Friday, December 20, 2019 10:13 AM EDT
Nabriva Therapeutics plc today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering of an aggregate of 13,793,106 ordinary shares.
In this article: NBRV
Jefferies Gives European Investors 'Christmas List Of 20 Stocks For 2020'
Week In Review: AlphaMab Raises $234 Million In Hong Kong IPO; Climbs 35% In First Trading Session
Article By:
ChinaBio® Today
Read
Saturday, December 14, 2019 5:09 PM EDT
Alphamab Oncology raised $234 million in a Hong Kong IPO and traded 35% higher from its offering price to a market cap of $1.2 billion. The company has a PD-L1 candidate that could be approved in China in 2020 and two bispecifics in Phase II tests.
Madrigal Pharmaceuticals Announces Pricing Of Secondary Offering
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, December 10, 2019 10:18 PM EDT
Madrigal Pharmaceuticals, Inc. today announced the pricing of the previously-announced underwritten secondary offering by investment funds affiliated with Bay City Capital LLC, of 1,200,000 shares of Madrigal’s common stock.
In this article: MDGL
Why Biotech ETFs Are Surging To New Highs
Video By:
Neena Mishra
Watch
Tuesday, December 10, 2019 10:00 PM EDT
We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive cancer treatment market.
Stock Charts To Watch - Tuesday, Dec. 10
Video By:
Harry Boxer
Watch
Tuesday, December 10, 2019 9:54 PM EDT
Amarin Corporation plc (AMRN) is looking well. After exploding, then pulling back and forming a wedge, AMRN finally started to trend upward in a nice pattern on Tuesday, breaking out of a wedge, and closing up 66 cents.
3 Stocks Showing Promising Technical Setups
Article By:
Jignesh Davda
Read
Sunday, December 8, 2019 12:44 PM EDT
There are three stocks I'm watching in the week ahead, Apple, Alphabet and Merck, all with setups on different time frames ranging from a weekly chart to a 4-hour chart.
Not Much Chemistry Between Sanofi And Hedge Funds
Article By:
Insider Monkey
Read
Saturday, December 7, 2019 8:43 PM EDT
Heading into the fourth quarter of 2019, a total of 27 of the hedge funds tracked by Insider Monkey were long Sanofi stock, a change of 8% from the second quarter of 2019.
US Stock Market Weekly Update December 2 - 6
Article By:
Stavros Georgiadis
Read
Saturday, December 7, 2019 7:43 PM EDT
A better than expected jobs report released on Friday was enough to send stocks higher at the close of the trading week. Economic fundamentals in the absence of rumors and statements about the US-China trade deal moved financial markets.